Welcome to the BioLogicTube jeo@biologicmedia.dk https://biologictube.dk/app/facebook en-us Visualplatform http://blogs.law.harvard.edu/tech/rss Welcome to the BioLogicTube episodic no https://biologictube.dk/app/facebook/files/rv0.0/sitelogo.gif https://biologictube.dk/app/facebook http://biologictube.dk/photo/7414280/the-brain-prize-meeting-at <p>As part of their outreach program, the&nbsp;Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark in late&nbsp;October 2012. The meeting allowed for interaction between the two brain prize winners, Karen Steel and Christine Petit, invited keynote speakers&nbsp;and brain researchers.&nbsp;<br></p><p><a href="http://biologictube.dk/photo/7414280/the-brain-prize-meeting-at"><img src="http://biologictube.dk/4959050/7414280/a8bc8786d85b2b4a77e8fae224c4e2fa/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/7414280 Thu, 06 Dec 2012 13:28:20 GMT The Brain Prize meeting at Hindsgavl October 2012 As part of their outreach program, theGrete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark in lateOctober 2012. The meeting allowed for interaction between the two brain prize winners, Karen Steel and Christine Petit, invited keynote speakersand brain researchers. As part of their outreach program, theGrete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark in lateOctober 2012. The meeting allowed for interaction between the two brain prize... Welcome to the BioLogicTube 05:00 <p>As part of their outreach program, the&nbsp;Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark in late&nbsp;October 2012. The meeting allowed for interaction between the two brain prize winners, Karen Steel and Christine Petit, invited keynote speakers&nbsp;and brain researchers.&nbsp;<br></p><p><a href="http://biologictube.dk/photo/7414280/the-brain-prize-meeting-at"><img src="http://biologictube.dk/4959050/7414280/a8bc8786d85b2b4a77e8fae224c4e2fa/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Genetic Kim Krogsgaard biologicmedia cochlear defness disease genes genomes hearing implant loss models mouse pathsways http://biologictube.dk/photo/6513381/brain-prize-2012-excerpts-from <p>In May 2012, Queen Margrethe II of Denmark handed The Grete Lundbeck European Brain Prize award to Christine Petit and Karen Steel ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’.The ceremony took place at the Black Diamond in Copenhagen, Denmark.</p> <p>For more information please contact:<br /> Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 <a href="mailto:kk@thebrainprize.org">kk@thebrainprize.org</a><br /> Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646<br /> Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen<br /> Denmark<br /> www.thebrainprize.org</p><p><a href="http://biologictube.dk/photo/6513381/brain-prize-2012-excerpts-from"><img src="http://biologictube.dk/4959050/6513381/25f88ace854eee4fbeb8b1952b451dc1/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/6513381 Fri, 06 Jul 2012 09:12:05 GMT Brain Prize 2012: Excerpts from the Prize Ceremony 2012-06-05 In May 2012, Queen Margrethe II of Denmark handed The Grete Lundbeck European Brain Prize award to Christine Petit and Karen Steel ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’.The ceremony took place at the Black Diamond in Copenhagen, Denmark. For more information please contact: Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 kk@thebrainprize.org Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646 Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen Denmark www.thebrainprize.org In May 2012, Queen Margrethe II of Denmark handed The Grete Lundbeck European Brain Prize award to Christine Petit and Karen Steel ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and... Welcome to the BioLogicTube 06:40 <p>In May 2012, Queen Margrethe II of Denmark handed The Grete Lundbeck European Brain Prize award to Christine Petit and Karen Steel ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’.The ceremony took place at the Black Diamond in Copenhagen, Denmark.</p> <p>For more information please contact:<br /> Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 <a href="mailto:kk@thebrainprize.org">kk@thebrainprize.org</a><br /> Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646<br /> Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen<br /> Denmark<br /> www.thebrainprize.org</p><p><a href="http://biologictube.dk/photo/6513381/brain-prize-2012-excerpts-from"><img src="http://biologictube.dk/4959050/6513381/25f88ace854eee4fbeb8b1952b451dc1/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> Deafness Kim Krogsgaard brain ear inner research http://biologictube.dk/photo/4959161/brain-prize-winners-2012-karen <p>The Grete Lundbeck European Brain Research Foundation has announced that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel:<br /> ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’.<br /> Inherited conditions render one in a thousand children deaf at birth, and cause as many again to become deaf before maturity, leading to delay or failure in the acquisition of speech, and frequently to disadvantages in communication and learning. Genetic anomalies also contribute to many age-related and progressive forms of hearing loss. About one-tenth of the population in the developed world suffers from significant hearing impairment, which has an enormous impact on individuals and on society.<br /> Karen Steel and Christine Petit are at the forefront of efforts to understand the molecular mechanisms of the specialised hair cells in the inner ear, whose extraordinary sensitivity to mechanical stimulation underpins the senses of hearing and balance. These two researchers, at the peak of their productivity and influence, are international leaders in the field of hereditary deafness.<br /> Each has brought special skill to this challenging area of research. Their approaches have been complementary. Karen Steel has worked upwards, employing elegant and exhaustive study of mutations in mice and their functional consequences to illuminate human disorders. Christine Petit has started with the genetic analysis of patients, subsequently investigating the role of the identified genes in animal model systems.<br /> Professor Colin Blakemore, Oxford University, Chairman of the Selection Committee said: ‘Together, the work of these two Europeans scientists illustrates the value and power of interdisciplinary approaches in neuroscience, and the way in which cutting-edge fundamental research is needed to understand complex clinical problems and to accelerate benefit for patients’.......’We are delighted that The Brain Prize for the best of European neuroscience goes, in its second year, to two<br /> Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark<br /> Tel. +45 3917 8240 <a href="mailto:info@thebrainprize.org">info@thebrainprize.org</a> www.thebrainprize.org<br /> 12 March 2012<br /> women scientists. We are sure that the award will be applauded by female researchers around the world, and by all those who are concerned that young women are given every encouragement to consider careers in science’<br /> The prize lectures and award ceremony will take place 9th May in Copenhagen, Denmark. The Prize will be presented by Her Majesty the Queen.<br /> Bios: Christine Petit, Professor at College de France, holding the Chair of Genetics and Cellular Physiology, head of the Genetics and Physiology of Hearing laboratory at the Institut Pasteur in Paris also affiliated to INSERM, is a geneticist and a neurobiologist. She conceived and pioneered the genetic strategy to assess the molecular mechanisms underlying the cochlear differentiation and physiology. She developed this genetic approach in humans, by succeeding to overcome the difficulties specific to linkage analysis for deafness. She thereby mapped to human chromosomes the first two genes responsible for hereditary congenital deafness. She identified the causative genes for about 20 inherited forms of deafness, initially by an innovative candidate gene approach. Together with her colleagues, she also unraveled the roles of most of the proteins encoded by these genes, namely in the sensory hair cells, their stimulating gel, and the supporting cells, by multidisciplinary studies of engineered mouse models. Her work shed light on the functions mediated through various fibrous links within the hair bundle, the mechanoreceptive structure to sound. Her work on Usher syndrome (deafness, blindness), demonstrated that all Usher 1 proteins as well as all Usher 2 proteins form protein networks enabling the links they form to shape the hair bundle. She also identified some Usher1 proteins as components of the mechanotransduction machinery. Christine Petit’s discoveries have already had a significant impact on medical practice, with respect to diagnosis, genetic counseling and therapeutic decisions by indicating the potential benefit of cochlear implants and hearing aids for patients.<br /> Karen Steel, Professor and Principal Investigator for the Genetics of Deafness and founder of the Mouse Genetics Programme at the Wellcome Trust Sanger Institute, Hinxton, near Cambridge, UK, has pioneered the use of mouse models, starting with her painstaking description of the characteristics of mutant mice with disorders of balance and hearing. Her early work on cochlear function and hair cell degeneration in the mutant deafness mouse led to identification of the gene called Tmc1, the human homologue of which is mutated in several forms of hereditary deafness. She and her colleagues went on to identify causative genes in nearly 30 forms of hearing disorder in mice, most of which have been linked to human conditions. In particular, she described the genes for myosin-7a and cadherin-23, which are key components in the transduction mechanism in hair cells, and mutations of which underlie forms of Usher Syndrome. Karen Steel is internationally recognized for her generous and altruistic approach to science. Working with a consortium of European researchers, she has established, catalogued and made freely available to other researchers<br /> several hundred mouse mutant lines, which have facilitated research in several areas of neuroscience around the world.<br /> About the Brain Prize The Brain Prize - € 1 million is awarded by Grete Lundbeck European Brain Research Foundation, a charitable, non-profit organization.<br /> The Brain Prize is a personal prize awarded to one or more scientists who have distinguished themselves by an outstanding contribution to European neuroscience.<br /> For more information please contact:<br /> Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 <a href="mailto:kk@thebrainprize.org">kk@thebrainprize.org</a><br /> Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646<br /> Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen<br /> Denmark<br /> www.thebrainprize.org</p><p><a href="http://biologictube.dk/photo/4959161/brain-prize-winners-2012-karen"><img src="http://biologictube.dk/4959050/4959161/221a778e8530641df57b207fd7d2b4ab/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/4959161 Sun, 06 May 2012 13:44:37 GMT Brain Prize Winners 2012 Karen Steel and Christine Petit The Grete Lundbeck European Brain Research Foundation has announced that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel: ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’. Inherited conditions render one in a thousand children deaf at birth, and cause as many again to become deaf before maturity, leading to delay or failure in the acquisition of speech, and frequently to disadvantages in communication and learning. Genetic anomalies also contribute to many age-related and progressive forms of hearing loss. About one-tenth of the population in the developed world suffers from significant hearing impairment, which has an enormous impact on individuals and on society. Karen Steel and Christine Petit are at the forefront of efforts to understand the molecular mechanisms of the specialised hair cells in the inner ear, whose extraordinary sensitivity to mechanical stimulation underpins the senses of hearing and balance. These two researchers, at the peak of their productivity and influence, are international leaders in the field of hereditary deafness. Each has brought special skill to this challenging area of research. Their approaches have been complementary. Karen Steel has worked upwards, employing elegant and exhaustive study of mutations in mice and their functional consequences to illuminate human disorders. Christine Petit has started with the genetic analysis of patients, subsequently investigating the role of the identified genes in animal model systems. Professor Colin Blakemore, Oxford University, Chairman of the Selection Committee said: ‘Together, the work of these two Europeans scientists illustrates the value and power of interdisciplinary approaches in neuroscience, and the way in which cutting-edge fundamental research is needed to understand complex clinical problems and to accelerate benefit for patients’.......’We are delighted that The Brain Prize for the best of European neuroscience goes, in its second year, to two Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark Tel. +45 3917 8240 info@thebrainprize.org www.thebrainprize.org 12 March 2012 women scientists. We are sure that the award will be applauded by female researchers around the world, and by all those who are concerned that young women are given every encouragement to consider careers in science’ The prize lectures and award ceremony will take place 9th May in Copenhagen, Denmark. The Prize will be presented by Her Majesty the Queen. Bios: Christine Petit, Professor at College de France, holding the Chair of Genetics and Cellular Physiology, head of the Genetics and Physiology of Hearing laboratory at the Institut Pasteur in Paris also affiliated to INSERM, is a geneticist and a neurobiologist. She conceived and pioneered the genetic strategy to assess the molecular mechanisms underlying the cochlear differentiation and physiology. She developed this genetic approach in humans, by succeeding to overcome the difficulties specific to linkage analysis for deafness. She thereby mapped to human chromosomes the first two genes responsible for hereditary congenital deafness. She identified the causative genes for about 20 inherited forms of deafness, initially by an innovative candidate gene approach. Together with her colleagues, she also unraveled the roles of most of the proteins encoded by these genes, namely in the sensory hair cells, their stimulating gel, and the supporting cells, by multidisciplinary studies of engineered mouse models. Her work shed light on the functions mediated through various fibrous links within the hair bundle, the mechanoreceptive structure to sound. Her work on Usher syndrome (deafness, blindness), demonstrated that all Usher 1 proteins as well as all Usher 2 proteins form protein networks enabling the links they form to shape the hair bundle. She also identified some Usher1 proteins as components of the mechanotransduction machinery. Christine Petit’s discoveries have already had a significant impact on medical practice, with respect to diagnosis, genetic counseling and therapeutic decisions by indicating the potential benefit of cochlear implants and hearing aids for patients. Karen Steel, Professor and Principal Investigator for the Genetics of Deafness and founder of the Mouse Genetics Programme at the Wellcome Trust Sanger Institute, Hinxton, near Cambridge, UK, has pioneered the use of mouse models, starting with her painstaking description of the characteristics of mutant mice with disorders of balance and hearing. Her early work on cochlear function and hair cell degeneration in the mutant deafness mouse led to identification of the gene called Tmc1, the human homologue of which is mutated in several forms of hereditary deafness. She and her colleagues went on to identify causative genes in nearly 30 forms of hearing disorder in mice, most of which have been linked to human conditions. In particular, she described the genes for myosin-7a and cadherin-23, which are key components in the transduction mechanism in hair cells, and mutations of which underlie forms of Usher Syndrome. Karen Steel is internationally recognized for her generous and altruistic approach to science. Working with a consortium of European researchers, she has established, catalogued and made freely available to other researchers several hundred mouse mutant lines, which have facilitated research in several areas of neuroscience around the world. About the Brain Prize The Brain Prize - € 1 million is awarded by Grete Lundbeck European Brain Research Foundation, a charitable, non-profit organization. The Brain Prize is a personal prize awarded to one or more scientists who have distinguished themselves by an outstanding contribution to European neuroscience. For more information please contact: Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 kk@thebrainprize.org Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646 Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen Denmark www.thebrainprize.org The Grete Lundbeck European Brain Research Foundation has announced that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel: ‘for their unique, world-leading contributions to our understanding of the genetic regulation of... Welcome to the BioLogicTube 03:28 <p>The Grete Lundbeck European Brain Research Foundation has announced that The Brain Prize 2012 is jointly awarded to Christine Petit and Karen Steel:<br /> ‘for their unique, world-leading contributions to our understanding of the genetic regulation of the development and functioning of the ear, and for elucidating the causes of many of the hundreds of inherited forms of deafness’.<br /> Inherited conditions render one in a thousand children deaf at birth, and cause as many again to become deaf before maturity, leading to delay or failure in the acquisition of speech, and frequently to disadvantages in communication and learning. Genetic anomalies also contribute to many age-related and progressive forms of hearing loss. About one-tenth of the population in the developed world suffers from significant hearing impairment, which has an enormous impact on individuals and on society.<br /> Karen Steel and Christine Petit are at the forefront of efforts to understand the molecular mechanisms of the specialised hair cells in the inner ear, whose extraordinary sensitivity to mechanical stimulation underpins the senses of hearing and balance. These two researchers, at the peak of their productivity and influence, are international leaders in the field of hereditary deafness.<br /> Each has brought special skill to this challenging area of research. Their approaches have been complementary. Karen Steel has worked upwards, employing elegant and exhaustive study of mutations in mice and their functional consequences to illuminate human disorders. Christine Petit has started with the genetic analysis of patients, subsequently investigating the role of the identified genes in animal model systems.<br /> Professor Colin Blakemore, Oxford University, Chairman of the Selection Committee said: ‘Together, the work of these two Europeans scientists illustrates the value and power of interdisciplinary approaches in neuroscience, and the way in which cutting-edge fundamental research is needed to understand complex clinical problems and to accelerate benefit for patients’.......’We are delighted that The Brain Prize for the best of European neuroscience goes, in its second year, to two<br /> Ole Maaløes Vej 3 DK-2200 Copenhagen N Denmark<br /> Tel. +45 3917 8240 <a href="mailto:info@thebrainprize.org">info@thebrainprize.org</a> www.thebrainprize.org<br /> 12 March 2012<br /> women scientists. We are sure that the award will be applauded by female researchers around the world, and by all those who are concerned that young women are given every encouragement to consider careers in science’<br /> The prize lectures and award ceremony will take place 9th May in Copenhagen, Denmark. The Prize will be presented by Her Majesty the Queen.<br /> Bios: Christine Petit, Professor at College de France, holding the Chair of Genetics and Cellular Physiology, head of the Genetics and Physiology of Hearing laboratory at the Institut Pasteur in Paris also affiliated to INSERM, is a geneticist and a neurobiologist. She conceived and pioneered the genetic strategy to assess the molecular mechanisms underlying the cochlear differentiation and physiology. She developed this genetic approach in humans, by succeeding to overcome the difficulties specific to linkage analysis for deafness. She thereby mapped to human chromosomes the first two genes responsible for hereditary congenital deafness. She identified the causative genes for about 20 inherited forms of deafness, initially by an innovative candidate gene approach. Together with her colleagues, she also unraveled the roles of most of the proteins encoded by these genes, namely in the sensory hair cells, their stimulating gel, and the supporting cells, by multidisciplinary studies of engineered mouse models. Her work shed light on the functions mediated through various fibrous links within the hair bundle, the mechanoreceptive structure to sound. Her work on Usher syndrome (deafness, blindness), demonstrated that all Usher 1 proteins as well as all Usher 2 proteins form protein networks enabling the links they form to shape the hair bundle. She also identified some Usher1 proteins as components of the mechanotransduction machinery. Christine Petit’s discoveries have already had a significant impact on medical practice, with respect to diagnosis, genetic counseling and therapeutic decisions by indicating the potential benefit of cochlear implants and hearing aids for patients.<br /> Karen Steel, Professor and Principal Investigator for the Genetics of Deafness and founder of the Mouse Genetics Programme at the Wellcome Trust Sanger Institute, Hinxton, near Cambridge, UK, has pioneered the use of mouse models, starting with her painstaking description of the characteristics of mutant mice with disorders of balance and hearing. Her early work on cochlear function and hair cell degeneration in the mutant deafness mouse led to identification of the gene called Tmc1, the human homologue of which is mutated in several forms of hereditary deafness. She and her colleagues went on to identify causative genes in nearly 30 forms of hearing disorder in mice, most of which have been linked to human conditions. In particular, she described the genes for myosin-7a and cadherin-23, which are key components in the transduction mechanism in hair cells, and mutations of which underlie forms of Usher Syndrome. Karen Steel is internationally recognized for her generous and altruistic approach to science. Working with a consortium of European researchers, she has established, catalogued and made freely available to other researchers<br /> several hundred mouse mutant lines, which have facilitated research in several areas of neuroscience around the world.<br /> About the Brain Prize The Brain Prize - € 1 million is awarded by Grete Lundbeck European Brain Research Foundation, a charitable, non-profit organization.<br /> The Brain Prize is a personal prize awarded to one or more scientists who have distinguished themselves by an outstanding contribution to European neuroscience.<br /> For more information please contact:<br /> Kim Krogsgaard, MD, DMSc or Director Mobile: +45 2014 8384 Phone: +45 3917 8240 <a href="mailto:kk@thebrainprize.org">kk@thebrainprize.org</a><br /> Nils Axelsen, MD, DMsc Chairman Mobile: +45 40548646<br /> Grete Lundbeck European Brain Research Foundation Ole Maaløes Vej 3 2200 N Copenhagen<br /> Denmark<br /> www.thebrainprize.org</p><p><a href="http://biologictube.dk/photo/4959161/brain-prize-winners-2012-karen"><img src="http://biologictube.dk/4959050/4959161/221a778e8530641df57b207fd7d2b4ab/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> BioLogicMedia Bjørn Christine Karen Petit Steel Vidø and brain daniel eugen-olsen frank jesper kim krogsgaard lone lundbeck neuroscience prize http://biologictube.dk/photo/4114610/brain-prize-winner-tams-freund <p>Prof. Tamás Freund's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4114610/brain-prize-winner-tams-freund"><img src="http://biologictube.dk/1984076/4114610/055aff67e0ea32d4a49a14ccd335a87b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/4114610 Tue, 13 Dec 2011 22:22:12 GMT Brain Prize winner Tamás Freund lecture on Endocannabinoid signalling in the... Prof. Tamás Freund's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers. Prof. Tamás Freund's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was... Welcome to the BioLogicTube 49:44 <p>Prof. Tamás Freund's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4114610/brain-prize-winner-tams-freund"><img src="http://biologictube.dk/1984076/4114610/055aff67e0ea32d4a49a14ccd335a87b/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> BioLogicMedia Kim Krogsgaard Outreach cells hungarian program research http://biologictube.dk/photo/4124687/prof-r-clay-reid-talks-on <p>Keynote lecture by Prof. R. Clay Reid. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4124687/prof-r-clay-reid-talks-on"><img src="http://biologictube.dk/1984072/4124687/d183aaafc489ed7966099087c278e192/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/4124687 Tue, 13 Dec 2011 22:15:32 GMT Prof. R. Clay Reid talks on Large scale structural and functional imaging of... Keynote lecture by Prof. R. Clay Reid. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers. Keynote lecture by Prof. R. Clay Reid. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish... Welcome to the BioLogicTube 39:00 <p>Keynote lecture by Prof. R. Clay Reid. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4124687/prof-r-clay-reid-talks-on"><img src="http://biologictube.dk/1984072/4124687/d183aaafc489ed7966099087c278e192/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> BioLogicMedia Kim Krogsgaard Nature brain cells pyramide http://biologictube.dk/photo/4130744/brain-prize-winner-gyorgy <p>Prof. Gyorgy Buzsáki's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4130744/brain-prize-winner-gyorgy"><img src="http://biologictube.dk/1984081/4130744/b02ee21b97f48ab195f3aed0c767f409/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/4130744 Tue, 13 Dec 2011 22:12:12 GMT Brain Prize winner Gyorgy Buzsáki talks on assembly organization by brain rhytms Prof. Gyorgy Buzsáki's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers. Prof. Gyorgy Buzsáki's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was... Welcome to the BioLogicTube 44:13 <p>Prof. Gyorgy Buzsáki's talk on his scientific work that led to the Brain Prize award. Grete Lundbeck European Brain Research Foundation hosted the annual Brain Prize Meeting at Hindsgavl Castle in Denmark from October 6-8th, 2011. The meeting was planned in collaboration with the Danish Neuroscience Schools and Danish Society for Neuroscience and it allowed for interaction between the three Hungarian prize winners and Danish brain researchers.</p><p><a href="http://biologictube.dk/photo/4130744/brain-prize-winner-gyorgy"><img src="http://biologictube.dk/1984081/4130744/b02ee21b97f48ab195f3aed0c767f409/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> BioLogicMedia Brain Hungarian Kim Krogsgaard Prize http://biologictube.dk/photo/3228526/pharmacosmos-cro <p>Pharmacosmos CRO<br /> Unique access to optimized global development<br /> We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies:<br /> • Integrated development planning through a senior development team<br /> • Patient recruitment in key global geographies through validated partners<br /> • Flexibility and agility of an SME<br /> • Global regulatory track record<br /> • Single point of contact<br /> We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network.<br /> We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration.<br /> Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions</p> <p>Our approach<br /> Optimizing global medical product development<br /> Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.<br /> For European biotech companies this approach maximize the value creation through<br /> • Easy access to a seasoned VP team of developers<br /> • Track record from CMC through to commercialization<br /> • Insight and experience to obtain key regulatory buy in from FDA and EMA<br /> • Patient recruitment in key global geographies<br /> For European pharmaceutical companies we add value through<br /> • Combining European, US and Indian core competences when executing your studies<br /> • Guiding and managing functional outsourcing of clinical development services<br /> • Obtaining and maintaining global registrations through our network<br /> This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place.<br /> <br /> <br /> Our team<br /> Identifying the most optimal plan to achieve your specific development goals<br /> Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals.</p> <p>Primary contact<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD</p> <p>Our VP team<br /> Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA</p> <p>Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc</p> <p>Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy</p> <p>Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA</p> <p>Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting<br /> <br /> <br /> To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte:<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: <a href="mailto:jsk@pharmacosmos.com">jsk@pharmacosmos.com</a><br /> Pharmacosmos CRO offices<br /> Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark<br /> Learn more about Pharmacosmos<br /> Visit our corporate website: www.pharmacosmos.com</p><p><a href="http://biologictube.dk/photo/3228526/pharmacosmos-cro"><img src="http://biologictube.dk/1984076/3228526/15181a34c38814f1299eaa0872884484/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> http://biologictube.dk/photo/3228526 Fri, 09 Sep 2011 16:45:51 GMT Pharmacosmos CRO Pharmacosmos CRO Unique access to optimized global development We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies: • Integrated development planning through a senior development team • Patient recruitment in key global geographies through validated partners • Flexibility and agility of an SME • Global regulatory track record • Single point of contact We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network. We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration. Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions Our approach Optimizing global medical product development Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners. For European biotech companies this approach maximize the value creation through • Easy access to a seasoned VP team of developers • Track record from CMC through to commercialization • Insight and experience to obtain key regulatory buy in from FDA and EMA • Patient recruitment in key global geographies For European pharmaceutical companies we add value through • Combining European, US and Indian core competences when executing your studies • Guiding and managing functional outsourcing of clinical development services • Obtaining and maintaining global registrations through our network This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place. Our team Identifying the most optimal plan to achieve your specific development goals Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals. Primary contact Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD Our VP team Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte: Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: jsk@pharmacosmos.com Pharmacosmos CRO offices Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark Learn more about Pharmacosmos Visit our corporate website: www.pharmacosmos.com Pharmacosmos CRO Unique access to optimized global development We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies: • Integrated development planning through a senior... Welcome to the BioLogicTube 01:02 <p>Pharmacosmos CRO<br /> Unique access to optimized global development<br /> We offer unique access to optimized global medical product development for European biotech and pharmaceutical companies:<br /> • Integrated development planning through a senior development team<br /> • Patient recruitment in key global geographies through validated partners<br /> • Flexibility and agility of an SME<br /> • Global regulatory track record<br /> • Single point of contact<br /> We have a track record for bringing new products from concept through to commercialization together with our dedicated and validated partner network.<br /> We have achieved registrations in more than 50 countries and registration times of less than 3 years from first-in-human to first registration.<br /> Our team provides the optimal solution to secure your specific milestones and regulatory objectives to satisfy your investors. What ever your needs, we always focus on delivering high quality solutions</p> <p>Our approach<br /> Optimizing global medical product development<br /> Our approach is to keep an in-house team of development executives to handle the strategic planning and manage plan execution. Execution is done through a global network of validated and audited partners.<br /> For European biotech companies this approach maximize the value creation through<br /> • Easy access to a seasoned VP team of developers<br /> • Track record from CMC through to commercialization<br /> • Insight and experience to obtain key regulatory buy in from FDA and EMA<br /> • Patient recruitment in key global geographies<br /> For European pharmaceutical companies we add value through<br /> • Combining European, US and Indian core competences when executing your studies<br /> • Guiding and managing functional outsourcing of clinical development services<br /> • Obtaining and maintaining global registrations through our network<br /> This way we accelerate clinical development at reduced cost, add flexibility, and help companies expand their commercialization to the global market place.<br /> <br /> <br /> Our team<br /> Identifying the most optimal plan to achieve your specific development goals<br /> Pharmacosmos CRO offers access to a seasoned VP team of developers spanning from CMC through to commercialization. Together, our team helps develop the most optimal plan to secure your specific development goals.</p> <p>Primary contact<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD</p> <p>Our VP team<br /> Claes Christian Strom 
Vice President, Medical Affairs
MD, PhD, BBA</p> <p>Lars Lykke Thomsen
 Vice President, Chief Medical Officer
MD, PhD, DMSc</p> <p>Kim Nordfjeld 
 Vice President, Quality and Registration
PhD Pharmacy</p> <p>Jens Fabricius
 Vice President, Marketing and Business Operations
BCommerce, EMBA</p> <p>Robert Guglielmetti 
Executive Vice President, Chief Financial Officer
MSc Accounting<br /> <br /> <br /> To learn more about Pharmacosmos CRO and our ability to secure your development milestone, please contact Jeppe Skytte:<br /> Jeppe Skytte 
Sales and Business Development Manager
MSc, PhD

T: +45 59 48 59 85 (direct)
T: +45 22 84 26 56 (mobile)
E: <a href="mailto:jsk@pharmacosmos.com">jsk@pharmacosmos.com</a><br /> Pharmacosmos CRO offices<br /> Pharmacosmos CRO A/S
Roervangsvej 30
DK-4300 Holbaek
Denmark<br /> Learn more about Pharmacosmos<br /> Visit our corporate website: www.pharmacosmos.com</p><p><a href="http://biologictube.dk/photo/3228526/pharmacosmos-cro"><img src="http://biologictube.dk/1984076/3228526/15181a34c38814f1299eaa0872884484/standard/download-1-thumbnail.jpg" width="600" height="338"/></a></p> CRO Christian Claes Fabricius Guglielmetti Jens Jeppe Kim Lars Lykke Nordfjeld Optimizing Pharmacosmos President Robert Skytte Strom Thomsen
 development global medical product 
Vice